Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model.
暂无分享,去创建一个
K. | K. Polonsky | S. Shoelson | A. Zeidler | A. Rubenstein | E. S. | H. Tager | A. | Shoelson | S. Polonsky | H. Rubenstein | Nahum
[1] M Fickova,et al. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Steiner,et al. Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Sanke,et al. Three mutant insulins in man , 1983, Nature.
[4] K. Polonsky,et al. Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism. , 1983, Acta endocrinologica.
[5] H. Maegawa,et al. Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues. Receptor binding and biological activity. , 1982, The Biochemical journal.
[6] E. Kaiser,et al. [LeuB24]insulin and [AlaB24]insulin: altered structures and cellular processing of B24-substituted insulin analogs. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[7] K. Polonsky,et al. Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. , 1982, The Journal of clinical investigation.
[8] [C-peptide and insulin in diabetics]. , 1982, Zhonghua yi xue za zhi.
[9] K. Polonsky,et al. Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog. , 1981, The Journal of clinical investigation.
[10] H. Kehlet,et al. Decreased insulin removal contributes to hyperinsulinemia in obesity. , 1981, The Journal of clinical endocrinology and metabolism.
[11] D. Robbins,et al. A human proinsulin variant at arginine 65 , 1981, Nature.
[12] P. De Meyts,et al. Impaired negative cooperativity of the semisynthetic analogues human [LeuB24]- and [LeuB25]-insulins. , 1981, Biochemical and biophysical research communications.
[13] D. Steiner,et al. Loss of a restriction endonuclease cleavage site in the gene of a structurally abnormal human insulin. , 1981, Biochemical and biophysical research communications.
[14] J. Olefsky,et al. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Olefsky,et al. Diabetes due to secretion of an abnormal insulin. , 1980, The New England journal of medicine.
[16] J. Olefsky,et al. A structurally abnormal insulin causing human diabetes , 1979, Nature.
[17] P. Savage,et al. C-Peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity. , 1979, The Journal of clinical endocrinology and metabolism.
[18] A. Rubenstein,et al. 31 – Insulin, Proinsulin, and C-Peptide , 1978 .
[19] D L Horwitz,et al. Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.
[20] D. Steiner,et al. Retention and degradation of 125I-insulin by perfused livers from diabetic rats. , 1976, The Journal of clinical investigation.